TimiCoin/TimiHealth Empowers Consumers to Retake Control of Their Genetic DNA Data

 

AUSTIN, Texas, Aug. 7, 2018 /PRNewswire/ -- Timicoin/TimiHealth, the first operating blockchain designed to empower every individual through the TimiDNA platform allows you to own, control, and monetize your genetic DNA data.

TimiHealth has developed the intellectual property that will protect individuals as they upload their data to the decentralized platform delivering on its trademark branding as the leader in "Tokenized Healthcareâ„¢."

There is no doubt that concerns about health care data-- particularly its security and privacy--have been escalating in recent years, said Will Lowe, founder and Managing Partner, Timicoin/TimiHealth.

The recent announcement that GlaxoSmithKline (GSK) is investing $300M in 23andMe to partner on leveraging genetic DNA data for pharmaceutical drug development with a 50/50 split on future profits further highlights the need for consumer ownership of their own data (https://www.gsk.com/en-gb/media/press-releases/gsk-and-23andme-sign-agreement-to-leverage-genetic-insights-for-the-development-of-novel-medicines/).

While we all support the development of beneficial, perhaps even disease-curing drugs, the subterfuge surrounding the use of people's personal health and genetic data is deeply concerning, said Lowe.

Millions of people pay companies like 23andMe, Ancestry.com, and Helix substantial fees to obtain information regarding their heritage, genetic disposition for certain disease states, or pharmacologic compatibility with drug regimens. Unfortunately, most consumers are unaware that the personal data gleaned from such tests can then be sold to any number of research organizations for huge profits--none of which are realized by the consumers themselves.

"TimiHealth and its TimiDNA platform is driven by a mission to remedy these inequities by enabling consumers to own, control, and secure the totality of their health data, including that about their genetic DNA. TimiHealth is built on the principles of trust, transparency and empowerment, with a goal of putting control back into the hands of the true owners of this valuable data--consumers themselves," said Lowe.

TimiHealth's blockchain technology secures health data in an ecosystem that allows individuals to see who wants to purchase their data, to determine whether or not that data is shared and/or sold, and to actually profit from sharing their information by tokenizing and monetizing said data.
TimiHealth encourages all individuals to take immediate control of their data with an option to earn the majority of the profits from the sale of the data.

Retaking Control of your DNA Data:

  1. First, all available data should be downloaded from each genetics company website into the secure TimiDNA blockchain platform (available August 20, 2018 at www.timicoin.io).
  2. Next, consumers should opt-out of all data sharing and marketing activities for each organization that holds their DNA data and request that it be deleted from their databases (https://www.businessinsider.com/how-to-delete-dna-genetic-data-2018-5).

Starting August 20th the first 100,000 individuals who upload their DNA data to the TimiDNA private and secure platform will receive 20 Timicoins and unlike other DNA storage facilities, individuals participating in the Timicoin Giveaway will stay in total control of their DNA.

About Timicoin/TimiHealth:
The Mobile Health Record Platform provides decentralized medical records from storing to accessing instantly from anywhere in the world in a secure exchange. Timicoin/TimiHealth (Timicoin.io) is a patent-pending solution to securing patient data, while providing unprecedented portability. The company is actively working on pilot programs in the US, Mexico City and Monterrey, Mexico.

Media Contact: Adrienne Mazzone 561-750-9800 x2270; amazzone@transmediagroup.com

View original content:http://www.prnewswire.com/news-releases/timicointimihealth-empowers-consumers-to-retake-control-of-their-genetic-dna-data-300692980.html

SOURCE TimiCoin/TimiHealth

Back to news